Home Tools
Log in
Cart

Search Result

Search Results for " tyrosine kinase inhibitor "

20

Compounds

Cat No. Product Name Synonyms Targets
T17184 Tyrosine kinase inhibitor c-Met/HGFR , Tyrosine Kinases
Tyrosine kinase inhibitor is a tyrosine kinase inhibitor used in combination with fragmenting aromatic nitrogen compounds as antiproliferative agents.
T60108 PDGFR Tyrosine Kinase Inhibitor III PDGF Receptor Tyrosine Kinase Inhibitor III PDGFR
PDGFR Tyrosine Kinase Inhibitor III (PDGF Receptor Tyrosine Kinase Inhibitor III) (PDGF Receptor Tyrosine Kinase Inhibitor III) is a multikinase inhibitor that inhibits PDGFR, EGFR, FGFR, PKA, and PKC, respectively. PDGF...
T4344 ALW-II-41-27 Eph receptor tyrosine kinase inhibitor Ephrin Receptor
ALW-II-41-27 (Eph receptor tyrosine kinase inhibitor), an Eph receptor tyrosine kinase inhibitor, is used for cancer therapy.
T21761 HNMPA IGF-1R
HNMPA is a membrane impermeable inhibitor of insulin receptor tyrosine kinase. HNMPA inhibits tyrosine and serine autophosphorylation by the human insulin receptor. HNMPA exhibits no effect on cyclic AMP-dependent prote...
T16730 Remibrutinib BTK
Remibrutinib inhibits BTK activity with an IC50 value of 0.023 μM in blood. Remibrutinib is an effective and orally active Bruton tyrosine kinase inhibitor (IC50: 1 nM). Remibrutinib has the potential for Chronic urticar...
T14692 BMX-IN-1 BMX kinase inhibitor BTK
BMX-IN-1 (BMX kinase inhibitor) is a selective inhibitor of bone marrow tyrosine kinase on chromosome X (BMX, IC50 = 8 nM) and the related Bruton’s tyrosine kinase (BTK, IC50 = 10.4 nM), but BMX-IN-1 is more than 47-656 ...
TQ0111 LDN-192960 DYRK , Haspin Kinase
LDN-192960 is a potent inhibitor of Haspin and DYRK2 (IC50s: 10 nM and 48 nM).
T5466 Tyrosine kinase-IN-1 VEGFR , FGFR , FLT , PDGFR
Tyrosine kinase-IN-1 is a multi-targeted tyrosine kinase inhibitor(KDR, Flt-1, FGFR1 and PDGFRα with IC50s of 4nM, 20nM, 4nM, 2 nM ,respectively)
T2431 ID-8 ID8 DYRK
ID-8, a DYRK inhibitor, sustains embryonic stem cell self-renewal in long-term culture.
T3041 ALK inhibitor 2 FAK , ALK
ALK inhibitor 2 is a new-type and selective inhibitor for the ALK kinase.
T2314 PF-431396 FAK , PYK2
PF-431396 is a dual PYK2/FAK inhibitor (IC50: 11/2 nM).
T11447 GNF4877 GSK-3 , DYRK
GNF4877 is a potent DYRK1A and GSK3β inhibitor (IC50s: 6 nM and 16 nM). It leads to blockade of nuclear factor of activated T-cells (NFATc) nuclear export and increased β-cell proliferation cells.
T6257 AZ191 DYRK
AZ191(IC50 of 17 nM) is an effective and specific DYRK1B inhibitor. The specificity of AZ191 for DYRK1B is about 5- and 110-fold greater over DYRK1A and DYRK2, respectively.
T15422 GSK-626616 DYRK
GSK-626616 is a potent and orally bioavailable DYRK3 inhibitor (IC50: 0.7 nM). It inhibits other members of the DYRK family with similar potency. GSK-626616 is a potential therapy for the treatment of anemia.
TN1433 Batatasin III FAK , Others , Akt
Batatasin III inhibits cancer migration and invasion by suppressing epithelial to mesenchymal transition and FAK-AKT signals and possesses anti-cancer activities. Batatasin III has a long-term inhibitory effect on whole-...
T10285 ALK inhibitor 1 FAK , IGF-1R , ALK
ALK inhibitor 1 is a selective ALK kinase inhibitor.
T6409 ALK kinase inhibitor-1 SAR348830 Others
SAR348830 is an ALK inhibitor, targeting anaplastic lymphoma kinase.
T14980 CLK-IN-T3 DYRK , CDK
CLK-IN-T3 is an inhibitor of CLK1, CLK2, and CLK3 with IC50s of 0.67, 15, and 110 nM. CLK-IN-T3 exhibits anti-cancer activity.
T8152 6-Demethoxytangeretin MAPK , ALK
6-Demethoxytangeretin is a citrus flavonoid isolated from Citrus depressa.
T1967 AZD-3463 ALK/IGF1R inhibitor Apoptosis , IGF-1R , ALK , Autophagy
AZD-3463 (ALK/IGF1R inhibitor) , an orally bioavailable ALK inhibitor (Ki: 0.75 nM), can inhibit IGF1R with equivalent potency.
1 2 3 4 5 ... 27
TargetMol